Serum Thrombopoietin Level in Various Hematological Diseases
Authors:
Open Access
- 1 September 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 14 (5) , 558-565
Abstract
To investigate the pathophysiological role of thrombopoietin (TPO) in thrombopoiesis, we measured its serum levels in 15 healthy individuals, 84 patients with various hematological diseases and 2 patients with liver cirrhosis using an enzyme immunoassay procedure. The TPO level was 0.84 ± 0.40 f mol/ml in normal individuals. TPO levels were considerably elevated in patients with myelosuppression after intensification chemotherapy of acute leukemia in complete remission (postchemotherapy group; n = 18; 18.46 ± 9.70 f mol/ml). When the data of normal individuals and the postchemotherapy group were combined, TPO levels were inversely correlated with the platelet count in this combined group. We compared these data of normal individuals and the postchemotherapy group with various hematological disease states. In aplastic anemia (n = 13; 16.03 ± 9.44 f mol/ml), acute lymphoblastic leukemia (n = 5; 10.36 ± 5.57 f mol/ml), malignant lymphoma (n = 6; 2.79 ± 2.27 f mol/ml), multiple myeloma (n = 3; 3.34 ± 0.20 f mol/ml) and chronic lymphocytic leukemia (n = 2; 1.71 ± 3.91 f mol/ml), the relationship of serum TPO levels and platelet counts was almost the same as in the combined group with normal individuals and the postchemotherapy group. However, the TPO levels were slightly higher in myeloproliferative disorders (n = 12; 1.99 ± 1.47 f mol/ml) and lower in acute myelogenous leukemia (n = 8; 2.27 ± 1.25 f mol/ml), hypoplastic leukemia (n = 3; 2.76 ± 2.23 f mol/ml), myelodysplastic syndrome (n = 2; 0.42 ± 0.60 f mol/ml), liver cirrhosis (n = 2; 1.50 ± 0.92 f mol/ml) and idiopathic thrombocytopenic purpura (n = 12; 2.08 ± 1.41 f mol/ml), when compared to the regression line for the combined group with normal individuals and postchemotherapy group. These findings suggest that TPO might play an important role in regulation of the platelet count in normal and pathological conditions.Keywords
This publication has 34 references indexed in Scilit:
- The sequence of a rat cDNA encoding thrombopoietinGene, 1995
- Molecular cloning and chromosomal localization of the human thrombopoietin geneFEBS Letters, 1994
- Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligandNature, 1994
- Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine.Proceedings of the National Academy of Sciences, 1990
- Effect of recombinant human erythropoietin on the anemia of chronic renal failureStem Cells, 1988
- Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.Proceedings of the National Academy of Sciences, 1987
- Effect of human recombinant erythropoietin on human marrow megakaryocyte colony formation in vitroBritish Journal of Haematology, 1987
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985
- Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)Annals of Internal Medicine, 1985
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982